✦ LIBER ✦

355 DISEASE MODIFYING DRUGS IN KNEE OSTEOARTHRITIS: CAN THEY BE COST-EFFECTIVE?

✍ Scribed by E. Losina; N.N. Niu; L.G. Suter; D.J. Hunter; H.L. Holt; H. Gerlovin; W.M. Reichmann; D.H. Solomon; R.P. Walensky; A.D. Paltiel; J.N. Katz

Book ID: 114351566
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 329 KB
Volume: 17
Category: Article
ISSN: 1063-4584
DOI: 10.1016/s1063-4584(09)60377-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-modifying drugs for knee osteoar

Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?

✍ Losina, E.; Daigle, M.E.; Suter, L.G.; Hunter, D.J.; Solomon, D.H.; Walensky, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 697 KB

Pharmacologic regimens for knee osteoart

Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

✍ Losina, E.; Burbine, S.A.; Suter, L.G.; Hunter, D.J.; Solomon, D.H.; Daigle, M.E 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 742 KB

I-8 OARSI-OMERACT SET OF CRITERIA IN KNE

I-8 OARSI-OMERACT SET OF CRITERIA IN KNEE/HIP OSTEOARTHRITIS TO BE USED AS A HARD ENDPOINT IN CLINICAL TRIALS EVALUATING POTENTIAL DISEASE-MODIFYING DRUGS

✍ L. Gossec 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

OARSI/OMERACT Criteria of Being Consider

OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs

✍ DOUGADOS, M.; HAWKER, G.; LOHMANDER, S.; DAVIS, A. M.; DIEPPE, P.; MAILLEFERT, J 📂 Article 📅 2009 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 82 KB